Prognosis provides a cloud-based platform for clinical trial supply chain forecasting and scenario planning. It streamlines data input and utilizes proprietary algorithms to generate rapid, actionable supply chain insights, enabling agile decision-making for pharmaceutical and biotech companies.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical trial supply chain forecasting is often a time-consuming process, requiring extensive manual data manipulation and complex modeling. This leads to delays in scenario planning and hinders the ability of teams to adapt quickly to changing trial parameters or unexpected supply chain disruptions.
Solution
Prognosis offers a cloud-based platform designed to streamline clinical trial supply chain forecasting and scenario planning. The system provides an intuitive user interface that allows for rapid input of trial parameters and supply chain data. Proprietary algorithms enable users to generate forecasts and evaluate multiple scenarios within minutes, facilitating agile decision-making. The platform supports secure data handling and compliance with industry standards, ensuring reliable and actionable insights for supply chain management.
Target Audience
The primary users are pharmaceutical and biotechnology companies involved in clinical trial management, specifically those responsible for supply chain logistics and planning.
Features
- User-friendly interface for intuitive data input and scenario configuration
- Rapid forecasting engine capable of generating supply chain projections in minutes
- Scenario planning functionality allowing for the evaluation of multiple "what-if" situations
- Flexible forecasting capabilities to accommodate diverse trial designs and supply chain complexities
- Secure, encrypted data storage with row-level security
- SOC 2 compliance in progress for enhanced data protection and governance
- Freemium tier for testing core features and initial trial planning
- Scalable architecture supporting multiple trial, compound, and scenario slots based on subscription tier